$0.14

(%)
Live
Previous Close

$0.14

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

NYSE American, LLC

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. ClearOne, Inc. (NASDAQ: CLRO) gained 85% to $1.51 after the company and Shure Incorporated announced they reached a global settlement of all pending legal disputes. Rockley Photonics Holdings Limited (NYSE: RKLY) rose 48.3% to $0.4218 after jumping 18% on Thursday. Rockley Photonics, last month, reported worse-than-expected Q3 sales results and issued 2022 revenue guidance below estimates. Marin Software Incorporated (NASDAQ: MRIN) shares climbed 34.5% to $1.52. Marin Software joined the Walmart Platform Partner program as an API partner. UpHealth, Inc. (NYSE: UPH) shares climbed 30.6% to $3.06. Healthcare transformation expert Timothy Wilde joined UpHealth as Chief Technology Officer. China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 29.4% to $2.7953. Hello Group Inc. (NASDAQ: MOMO) jumped 29% to $8.77. Morgan Stanley upgraded Hello Group from Equal-Weight to Overweight and raised the price target from $5 to $9. Arcellx, Inc. (NASDAQ: ACLX) gained 27.8% to $27.71. Kite, a Gilead Sciences Inc company, announced a global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for relapsed or refractory multiple myeloma. Arcellx also announced interim CART-ddBCMA Phase 1 results (October 31, 2022 cutoff date), demonstrating deep and durable responses. Baudax Bio, Inc. (NASDAQ: BXRX) shares gained 23% to $5.01 after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Daktronics, Inc. (NASDAQ: DAKT) jumped 23% to $2.1518. Daktronics delayed its earnings release to address the determination that there is 'substantial doubt' over its ability to continue as a going concern. Acer Therapeutics Inc. (NASDAQ: ACER) gained 21% to $1.90. Acer Therapeutics recently reported a $1.5 million private placement. HUYA Inc. (NYSE: HUYA) rose 20.6% to $3.39. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares rose 20.4% to $2.0907 after gaining 25% on Thursday. Ladenburg Thalmann recently initiated coverage on NeuroBo Pharmaceuticals with a Buy rating and announced ...

Related tickers: TIVC, PRTY, ARMP, WAVD, MOMO, BXRX, CLRO, ACLX, DOMO, UPH, DAKT, SBIG, MYSZ, PHVS, FIZZ, SHFS, STG, IKNA, JOUT, BIVI, MMAT, LULU, ACER, RNAZ, RENT, ZEST, SVFD, KEP, FLGC, GROM, PHR, DOCU, AMAM, ICLK, HUYA, CURV, AVGO, BHR, ENSC, CJJD, AUTL, ERAS, RKLY, SEV, SXTC, WBEV, NRBO, HARP, BJDX, MRIN, PBTS.

Read Full Article

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint. TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares climbed 59.1% to $0.6679 after the company reported withdrawal of registration statement. BioVie Inc. (NASDAQ: BIVI) gained 26.2% to $5.87. BioVie recently announced results from two Phase 2 trials assessing NE3107's potential in Parkinson's Disease (PD) and Alzheimer's Disease (AD). Bit Brother Limited (NASDAQ: BTB) climbed 23.1% to $0.4680. Vor Biopharma Inc. (NASDAQ: VOR) climbed 21.4% to $5.22 after the company disclosed initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia. Vor Bio also priced underwritten offering of 15.3 million shares of common stock at $4.30 per share. FLJ Group Limited (NASDAQ: FLJ) gained 19.1% to $1.59. MongoDB, Inc. (NASDAQ: MDB) climbed 18.6% to $171.54 after the company reported better-than-expected sales results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates. Titan Medical Inc. (NASDAQ: TMDI) gained 17.8% to $0.7099. Titan Medical suspended special meeting of shareholders in conjunction with initiation of strategic review process. Yield10 Bioscience, Inc. (NASDAQ: YTEN) climbed 15.6% to $2.0799. Yield10 Bioscience, last month, posted a Q3 loss of $0.71 per share. Replimune Group, Inc. (NASDAQ: REPL) rose 15.5% to $21.82 after the company announced it entered into a collaboration angreement with Roche, and also announced initial data from the anti-PD1 failed melanoma cohort of the IGNYTE clinical trial and an RP2/3 program update. Hillstream BioPharma, Inc. (NASDAQ: HILS) gained 14.2% to $0.4799. Hillstream BioPharma recently announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1. NEXGEL, Inc. (NASDAQ: NXGL) gained 14.1% to $1.3690. NEXGEL reported share repurchase program of up to $500,000 of the company’s common stock. Wearable Devices Ltd. (NASDAQ: WLDS) jumped ...

Related tickers: GOSS, NXGL, RXDX, CTRM, HILS, GDS, XFOR, ASO, ANGH, COSM, POAI, DDI, TMPO, BIVI, DUO, DAKT, ALVO, YTEN, INVO, EZPW, BRSH, UNIT, SWBI, SKIL, WLDS, CVNA, VOR, UNFI, FLJ, BRQS, MDB, MMAT, CEA, SLNA, CDMO, RNAZ, MTB, VS, GROM, STT, QRTEB, BTB, IBIO, ZUO, ENSC, KC, LOVE, VGFC, REPL, TMDI, WBEV, WORX, NIU, TROO, MRTX.

Read Full Article
Trending Tickers

Please sign in to view